{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:54Z","timestamp":1792782834402,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The National Key R&D Program of China","award":["2022YFC2303202"],"award-info":[{"award-number":["2022YFC2303202"]}]},{"name":"The CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-037"],"award-info":[{"award-number":["2021-I2M-1-037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10096-024-04777-z","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T22:02:21Z","timestamp":1708552941000},"page":"809-820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study"],"prefix":"10.1007","volume":"43","author":[{"given":"Xuefang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonglei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhi","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"4777_CR1","unstructured":"World Health Organization. Global Tuberculosis Report (2023) Geneva: World Health Organization, 2023."},{"issue":"10","key":"4777_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ (2016) The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 13(10):e1002152. https:\/\/doi.org\/10.1371\/journal.pmed.1002152","journal-title":"PLoS Med"},{"key":"4777_CR3","volume-title":"WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: module 1: prevention","author":"World Health Organization","year":"2020","unstructured":"World Health Organization (2020) WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: module 1: prevention. World Health Organization, Geneva"},{"issue":"10","key":"4777_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1473-3099(17)30402-4","volume":"17","author":"L Gao","year":"2017","unstructured":"Gao L, Li X, Liu J, Wang X, Lu W, Bai L et al (2017) Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis 17(10):1053\u20131061. https:\/\/doi.org\/10.1016\/S1473-3099(17)30402-4","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"4777_CR5","doi-asserted-by":"publisher","first-page":"1801470","DOI":"10.1183\/13993003.01470-2018","volume":"52","author":"L Gao","year":"2018","unstructured":"Gao L, Zhang H, Xin H, Liu J, Pan S, Li X et al (2018) Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study. Eur Respir J 52(6):1801470. https:\/\/doi.org\/10.1183\/13993003.01470-2018","journal-title":"Eur Respir J"},{"issue":"16","key":"4777_CR6","first-page":"920","volume":"18","author":"Ma Liping","year":"2003","unstructured":"Liping Ma (2003) Study on the incidence and prevention of tuberculosis infection among close contacts in families of infectious pulmonary tuberculosis patients. Clinical Focus 18(16):920\u2013922","journal-title":"Clinical Focus"},{"key":"4777_CR7","first-page":"139","volume":"27","author":"YQ Liu","year":"2005","unstructured":"Liu YQ, Tu DH, An YS, Zhang LX (2005) Tuberculosis control in college students in Beijing: preventive therapy for tuberculosis-infected persons. Chin J Antitubercul 27:139\u2013142","journal-title":"Chin J Antitubercul"},{"issue":"3","key":"4777_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1473-3099(14)71085-0","volume":"15","author":"L Gao","year":"2015","unstructured":"Gao L, Lu W, Bai L, Wang X, Xu J, Catanzaro A et al (2015) Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis 15(3):310\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(14)71085-0","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4777_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1183\/13993003.00235-2016","volume":"48","author":"L Gao","year":"2016","unstructured":"Gao L, Bai L, Liu J, Lu W, Wang X, Li X et al (2016) Annual risk of tuberculosis infection in rural China: a population-based prospective study. Eur Respir J 48(1):168\u2013178. https:\/\/doi.org\/10.1183\/13993003.00235-2016","journal-title":"Eur Respir J"},{"issue":"1","key":"4777_CR10","doi-asserted-by":"publisher","first-page":"2102359","DOI":"10.1183\/13993003.02359-2021","volume":"60","author":"H Xin","year":"2022","unstructured":"Xin H, Cao X, Zhang H, Feng B, Du Y, Zhang B et al (2022) Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial. Eur Respir J 60(1):2102359. https:\/\/doi.org\/10.1183\/13993003.02359-2021","journal-title":"Eur Respir J"},{"issue":"8","key":"4777_CR11","doi-asserted-by":"publisher","first-page":"e00427","DOI":"10.1128\/JCM.00427-18","volume":"56","author":"JY Chien","year":"2018","unstructured":"Chien JY, Chiang HT, Lu MC, Ko WC, Yu CJ, Chen YH et al (2018) QuantiFERON-TB Gold Plus is a more sensitive screening tool than QuantiFERON-TB Gold In-Tube for latent tuberculosis infection among older adults in long-term care facilities. J Clin Microbiol 56(8):e00427-e518. https:\/\/doi.org\/10.1128\/JCM.00427-18","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4777_CR12","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1016\/j.ijid.2009.05.007","volume":"14","author":"J Li","year":"2010","unstructured":"Li J, Munsiff SS, Tarantino T, Dorsinville M (2010) Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis 14(4):e292\u2013e297. https:\/\/doi.org\/10.1016\/j.ijid.2009.05.007","journal-title":"Int J Infect Dis"},{"issue":"9","key":"4777_CR13","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cmi.2019.01.021","volume":"25","author":"H Xin","year":"2019","unstructured":"Xin H, Zhang H, Liu J, Pan S, Li X, Cao X et al (2019) Mycobacterium tuberculosis infection among the elderly in 20 486 rural residents aged 50\u201370 years in Zhongmu County China. Clin Microbiol Infect 25(9):1120\u20131126. https:\/\/doi.org\/10.1016\/j.cmi.2019.01.021","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"4777_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1164\/arrd.1979.119.5.827","volume":"119","author":"GW Comstock","year":"1979","unstructured":"Comstock GW, Baum C, Snider DE Jr (1979) Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis 119(5):827\u201330. https:\/\/doi.org\/10.1164\/arrd.1979.119.5.827","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"4777_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.19982\/j.issn.1000-6621.20210661","volume":"44","author":"L Gao","year":"2022","unstructured":"Gao L, Zhang H, Hu MG, Xu CD, Xia YY, Li T et al (2022) Estimation of the national burden on latent tuberculosis infection based a multi-center epidemiological survey and the space statistics mode. Chinese Journal of Antituberculosis 44(1):54\u201359. https:\/\/doi.org\/10.19982\/j.issn.1000-6621.20210661","journal-title":"Chinese Journal of Antituberculosis"},{"issue":"4","key":"4777_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1378\/chest.09-2350","volume":"137","author":"R Diel","year":"2010","unstructured":"Diel R, Loddenkemper R, Nienhaus A (2010) Evidence-based comparison of commercial interferon-\u03b3 release assays for detecting active TB: a meta analysis. Chest 137(4):952\u2013968. https:\/\/doi.org\/10.1378\/chest.09-2350","journal-title":"Chest"},{"issue":"5","key":"4777_CR17","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1093\/cid\/ciaa1822","volume":"73","author":"CE Oh","year":"2021","unstructured":"Oh CE, Ortiz-Brizuela E, Bastos ML, Menzies D (2021) Comparing the diagnostic performance of QuantiFERON-TB Gold Plus to other tests of latent tuberculosis infection: a systematic review and meta-analysis. Clin Infect Dis 73(5):e1116\u2013e1125. https:\/\/doi.org\/10.1093\/cid\/ciaa1822","journal-title":"Clin Infect Dis"},{"key":"4777_CR18","first-page":"257","volume":"133","author":"D Menzies","year":"2011","unstructured":"Menzies D, Al Jahdali H, Al Otaibi B (2011) Recent developments in treatment of latent tuberculosis infection. Indian J Med Res 133:257\u2013266","journal-title":"Indian J Med Res"},{"issue":"1","key":"4777_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jval.2012.09.006","volume":"16","author":"M Sadatsafavi","year":"2013","unstructured":"Sadatsafavi M, Marra C, Marra F, Moran O, FitzGerald JM, Lynd L (2013) A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Value Health 16(1):66\u201375. https:\/\/doi.org\/10.1016\/j.jval.2012.09.006","journal-title":"Value Health"},{"key":"4777_CR20","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2015","unstructured":"World Health Organization (2015) Global tuberculosis report. World Health Organization, Geneva"},{"issue":"4","key":"4777_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/00365540903493723","volume":"42","author":"B Abuaku","year":"2010","unstructured":"Abuaku B, Tan H, Li X, Chen M, Huang X (2010) Treatment default and death among tuberculosis patients in Hunan. China Scand J Infect Dis 42(4):281\u2013287. https:\/\/doi.org\/10.3109\/00365540903493723","journal-title":"China Scand J Infect Dis"},{"issue":"4","key":"4777_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2213-2600(20)30039-4","volume":"8","author":"M Quaife","year":"2020","unstructured":"Quaife M, Houben RMGJ, Allwood B, Cohen T, Coussens AK, Harries AD et al (2020) Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. Lancet Respir Med 8(4):332\u2013333. https:\/\/doi.org\/10.1016\/S2213-2600(20)30039-4","journal-title":"Lancet Respir Med"},{"issue":"8","key":"4777_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3967\/bes2016.083","volume":"29","author":"N Wang","year":"2016","unstructured":"Wang N, Ma Y, Liu YH, DU J, Zhang H, Xie SH, et al (2016) Risk of treatment failure in patients with drug-susceptible pulmonary tuberculosis in China. Biomed Environ Sci 29(8):612\u2013617. https:\/\/doi.org\/10.3967\/bes2016.083","journal-title":"Biomed Environ Sci"},{"issue":"4","key":"4777_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cmi.2017.07.008","volume":"24","author":"L Zhang","year":"2018","unstructured":"Zhang L, Meng Q, Chen S, Zhang M, Chen B, Wu B et al (2018) Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009\u20132013. Clin Microbiol Infect 24(4):381\u2013388. https:\/\/doi.org\/10.1016\/j.cmi.2017.07.008","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"4777_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cmi.2021.09.022","volume":"28","author":"QL Ruan","year":"2022","unstructured":"Ruan QL, Yang QL, Sun F, Liu W, Shen YJ, Wu J et al (2022) Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China. Clin Microbiol Infect 28(5):684\u2013689. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.022","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"4777_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.cmi.2022.05.019","volume":"28","author":"Q Liu","year":"2022","unstructured":"Liu Q, Qiu B, Li G, Yang T, Tao B, Martinez L et al (2022) Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing. Clin Microbiol Infect 28(11):1458\u20131464. https:\/\/doi.org\/10.1016\/j.cmi.2022.05.019","journal-title":"Clin Microbiol Infect"},{"key":"4777_CR27","unstructured":"Zu Xiaowen (2021) Cost-effectiveness of preventive treatment for close contacts of tuberculosis patients. China Center for Disease Control and Prevention. https:\/\/kns.cnki.net\/kcms\/detail\/detail.aspx?FileName=1021001822.nh&DbName=CMFD2021."},{"issue":"1","key":"4777_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40249-019-0564-2","volume":"8","author":"CH Xu","year":"2019","unstructured":"Xu CH, Jeyashree K, Shewade HD, Xia YY, Wang LX, Liu Y et al (2019) Inequity in catastrophic costs among tuberculosis-affected households in China. Infect Dis Poverty 8(1):46. https:\/\/doi.org\/10.1186\/s40249-019-0564-2","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"4777_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029775","volume":"7","author":"W Kittikraisak","year":"2012","unstructured":"Kittikraisak W, Kingkaew P, Teerawattananon Y, Yothasamut J, Natesuwan S, Manosuthi W et al (2012) Health related quality of life among patients with tuberculosis and HIV in Thailand. PLoS ONE 7(1):e29775. https:\/\/doi.org\/10.1371\/journal.pone.0029775","journal-title":"PLoS ONE"},{"issue":"11","key":"4777_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1164\/rccm.200901-0153OC","volume":"179","author":"DP Holland","year":"2009","unstructured":"Holland DP, Sanders GD, Hamilton CD, Stout JE (2009) Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection. Am J Respir Crit Care Med 179(11):1055\u20131060. https:\/\/doi.org\/10.1164\/rccm.200901-0153OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4777_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2021.100262","volume":"24","author":"G Ilaiwy","year":"2021","unstructured":"Ilaiwy G, Dowdy DW (2021) Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees. J Clin Tuberc Other Mycobact Dis 24:100262. https:\/\/doi.org\/10.1016\/j.jctube.2021.100262","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"11","key":"4777_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/jac\/dky403","volume":"179","author":"TN Doan","year":"2009","unstructured":"Doan TN, Fox GJ, Meehan MT, Scott N, Ragonnet R, Viney K et al (2009) Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study. Am J Respir Crit Care Med 179(11):1055\u20131060. https:\/\/doi.org\/10.1093\/jac\/dky403","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4777_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12879-022-07465-5","volume":"22","author":"Z Wen","year":"2022","unstructured":"Wen Z, Li T, Zhu W, Chen W, Zhang H, Wang W (2022) Effect of different interventions for latent tuberculosis infections in China: a model-based study. BMC Infect Dis 22(1):488. https:\/\/doi.org\/10.1186\/s12879-022-07465-5","journal-title":"BMC Infect Dis"},{"key":"4777_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12916-015-0341-4","volume":"13","author":"GH Huynh","year":"2015","unstructured":"Huynh GH, Klein DJ, Chin DP, Wagner BG, Eckhoff PA, Liu R, Wang L (2015) Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med 13:88. https:\/\/doi.org\/10.1186\/s12916-015-0341-4","journal-title":"BMC Med"},{"issue":"5","key":"4777_CR35","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/cid\/ciz581","volume":"70","author":"H Xin","year":"2020","unstructured":"Xin H, Zhang H, Yang S, Liu J, Lu W, Bai L et al (2020) 5-year follow-up of active tuberculosis development from latent infection in rural China. Clin Infect Dis 70(5):947\u2013950. https:\/\/doi.org\/10.1093\/cid\/ciz581","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4777_CR36","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2169195","volume":"12","author":"H Zhang","year":"2023","unstructured":"Zhang H, Xin H, Du Y, Cao X, Pan S, Liu J et al (2023) Tuberculosis preventive treatment among individuals with inactive tuberculosis suggested by untreated radiographic abnormalities: a community-based randomized controlled trial. Emerg Microbes Infect 12(1):e2169195. https:\/\/doi.org\/10.1080\/22221751.2023.2169195","journal-title":"Emerg Microbes Infect"},{"key":"4777_CR37","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1186\/s12889-015-2530-7","volume":"15","author":"LT Wingate","year":"2015","unstructured":"Wingate LT, Coleman MS, de la Motte HC, Semple M, Zhou W, Cetron MS et al (2015) A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program. BMC Public Health 15:1201. https:\/\/doi.org\/10.1186\/s12889-015-2530-7","journal-title":"BMC Public Health"},{"issue":"4","key":"4777_CR38","first-page":"471","volume":"14","author":"S Deuffic-Burban","year":"2010","unstructured":"Deuffic-Burban S, Atsou K, Viget N, Melliez H, Bouvet E, Yazdanpanah Y (2010) Cost effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection. Int J Tuberc Lung Dis 14(4):471\u201381","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"4777_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2466-10-7","volume":"22","author":"A Pooran","year":"2010","unstructured":"Pooran A, Booth H, Miller RF, Scott G, Badri M, Huggett JF et al (2010) Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med 22(10):7. https:\/\/doi.org\/10.1186\/1471-2466-10-7","journal-title":"BMC Pulm Med"},{"key":"4777_CR40","unstructured":"Rapid communication: TB antigen-based skin tests for the diagnosis of TB infection (2022) Geneva: World Health Organization."}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04777-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04777-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:06:55Z","timestamp":1716268015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04777-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["4777"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04777-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"21 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As human subjects were not involved, ethics approval was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}